Shaw Kevin G. has filed 4 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 8270 shares of NextCure, Inc. ($NXTC) on January 30, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | NextCure, Inc. | $NXTC | Shaw Kevin G. | Sr VP, General Counsel | A | Employee Stock Option (Right to Buy) | 8270 | $0.00 | 8,270.0000 | 2,842,448 | 9999.99% | 0.29% |
| Jan. 31, 2025 | NextCure, Inc. | $NXTC | Shaw Kevin G. | Sr VP, General Counsel | A | Employee Stock Option (Right to Buy) | 66125 | $0.00 | 66,125.0000 | 2,330,386 | 9999.99% | 2.84% |
| March 29, 2024 | NextCure, Inc. | $NXTC | Shaw Kevin G. | Sr VP, General Counsel | A | Employee Stock Option (Right to Buy) | 93900 | $0.00 | 93,900.0000 | 27,836,584 | 9999.99% | 0.34% |
| Jan. 31, 2024 | NextCure, Inc. | $NXTC | Shaw Kevin G. | Sr VP, General Counsel | A | Employee Stock Option (Right to Buy) | 66125 | $0.00 | 66,125.0000 | 27,836,584 | 9999.99% | 0.24% |